These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20344052)

  • 1. Studies in human malaria; the protective action of sulfadiazine against sporozoite-induced falciparum malaria.
    COATNEY GR; COOPER WC
    Am J Hyg; 1947 Jul; 46(1):84-104. PubMed ID: 20344052
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies in human malaria; the suppressive action of sulfadiazine and sulfapyrazine against sporozoite-induced vivax malaria (St. Elizabeth strain).
    COATNEY GR; COOPER WC
    Am J Hyg; 1947 Jul; 46(1):105-18. PubMed ID: 20252852
    [No Abstract]   [Full Text] [Related]  

  • 3. Early activity in sporozoite-induced Plasmodium falciparum infections.
    JEFFERY GM; YOUNG MD; BURGESS RW; EYLES DE
    Ann Trop Med Parasitol; 1959 Apr; 53(1):51-8. PubMed ID: 13650489
    [No Abstract]   [Full Text] [Related]  

  • 4. AMA1 and MAEBL are important for Plasmodium falciparum sporozoite infection of the liver.
    Yang ASP; Lopaticki S; O'Neill MT; Erickson SM; Douglas DN; Kneteman NM; Boddey JA
    Cell Microbiol; 2017 Sep; 19(9):. PubMed ID: 28371168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity.
    Silvie O; Rubinstein E; Franetich JF; Prenant M; Belnoue E; Rénia L; Hannoun L; Eling W; Levy S; Boucheix C; Mazier D
    Nat Med; 2003 Jan; 9(1):93-6. PubMed ID: 12483205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A linear peptide containing minimal T- and B-cell epitopes of Plasmodium falciparum circumsporozoite protein elicits protection against transgenic sporozoite challenge.
    Calvo-Calle JM; Oliveira GA; Watta CO; Soverow J; Parra-Lopez C; Nardin EH
    Infect Immun; 2006 Dec; 74(12):6929-39. PubMed ID: 17030584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infectivity of
    McCall MBB; Wammes LJ; Langenberg MCC; van Gemert GJ; Walk J; Hermsen CC; Graumans W; Koelewijn R; Franetich JF; Chishimba S; Gerdsen M; Lorthiois A; van de Vegte M; Mazier D; Bijker EM; van Hellemond JJ; van Genderen PJJ; Sauerwein RW
    Sci Transl Med; 2017 Jun; 9(395):. PubMed ID: 28637923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of CD4+CD45RO+ T lymphocytes producing IL-4 in response to antigens on Plasmodium falciparum erythrocytes: an in vitro correlate of protective immunity induced with attenuated Plasmodium falciparum sporozoites.
    Bergmann ES; Ballou RW; Krzych U
    Cell Immunol; 1997 Sep; 180(2):143-52. PubMed ID: 9341744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of whole sporozoite malaria vaccines.
    Hollingdale MR; Sedegah M
    Expert Rev Vaccines; 2017 Jan; 16(1):45-54. PubMed ID: 27327875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sporozoite transmission by Anopheles freeborni and Anopheles gambiae experimentally infected with Plasmodium falciparum.
    Beier JC; Beier MS; Vaughan JA; Pumpuni CB; Davis JR; Noden BH
    J Am Mosq Control Assoc; 1992 Dec; 8(4):404-8. PubMed ID: 1474388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A genetically attenuated malaria vaccine candidate based on P. falciparum b9/slarp gene-deficient sporozoites.
    van Schaijk BC; Ploemen IH; Annoura T; Vos MW; Foquet L; van Gemert GJ; Chevalley-Maurel S; van de Vegte-Bolmer M; Sajid M; Franetich JF; Lorthiois A; Leroux-Roels G; Meuleman P; Hermsen CC; Mazier D; Hoffman SL; Janse CJ; Khan SM; Sauerwein RW
    Elife; 2014 Nov; 3():. PubMed ID: 25407681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The whole parasite, pre-erythrocytic stage approach to malaria vaccine development: a review.
    Epstein JE; Richie TL
    Curr Opin Infect Dis; 2013 Oct; 26(5):420-8. PubMed ID: 23982233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the adequacy of attenuation of genetically modified malaria parasite vaccine candidates.
    Annoura T; Ploemen IH; van Schaijk BC; Sajid M; Vos MW; van Gemert GJ; Chevalley-Maurel S; Franke-Fayard BM; Hermsen CC; Gego A; Franetich JF; Mazier D; Hoffman SL; Janse CJ; Sauerwein RW; Khan SM
    Vaccine; 2012 Mar; 30(16):2662-70. PubMed ID: 22342550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin scarification with Plasmodium falciparum peptide vaccine using synthetic TLR agonists as adjuvants elicits malaria sporozoite neutralizing immunity.
    Mitchell RA; Altszuler R; Frevert U; Nardin EH
    Sci Rep; 2016 Sep; 6():32575. PubMed ID: 27624667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete attenuation of genetically engineered Plasmodium falciparum sporozoites in human subjects.
    Kublin JG; Mikolajczak SA; Sack BK; Fishbaugher ME; Seilie A; Shelton L; VonGoedert T; Firat M; Magee S; Fritzen E; Betz W; Kain HS; Dankwa DA; Steel RW; Vaughan AM; Noah Sather D; Murphy SC; Kappe SH
    Sci Transl Med; 2017 Jan; 9(371):. PubMed ID: 28053159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malaria vaccine candidate antigen targeting the pre-erythrocytic stage of Plasmodium falciparum produced at high level in plants.
    Voepel N; Boes A; Edgue G; Beiss V; Kapelski S; Reimann A; Schillberg S; Pradel G; Fendel R; Scheuermayer M; Spiegel H; Fischer R
    Biotechnol J; 2014 Nov; 9(11):1435-45. PubMed ID: 25200253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene disruption of Plasmodium falciparum p52 results in attenuation of malaria liver stage development in cultured primary human hepatocytes.
    van Schaijk BC; Janse CJ; van Gemert GJ; van Dijk MR; Gego A; Franetich JF; van de Vegte-Bolmer M; Yalaoui S; Silvie O; Hoffman SL; Waters AP; Mazier D; Sauerwein RW; Khan SM
    PLoS One; 2008; 3(10):e3549. PubMed ID: 18958160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mosquito bite immunization with radiation-attenuated Plasmodium falciparum sporozoites: safety, tolerability, protective efficacy and humoral immunogenicity.
    Hickey BW; Lumsden JM; Reyes S; Sedegah M; Hollingdale MR; Freilich DA; Luke TC; Charoenvit Y; Goh LM; Berzins MP; Bebris L; Sacci JB; De La Vega P; Wang R; Ganeshan H; Abot EN; Carucci DJ; Doolan DL; Brice GT; Kumar A; Aguiar J; Nutman TB; Leitman SF; Hoffman SL; Epstein JE; Richie TL
    Malar J; 2016 Jul; 15(1):377. PubMed ID: 27448805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow Cytometry-Based Assessment of Antibody Function Against Malaria Pre-erythrocytic Infection.
    Douglass AN; Metzger PG; Kappe SH; Kaushansky A
    Methods Mol Biol; 2015; 1325():49-58. PubMed ID: 26450378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against a malaria challenge by sporozoite inoculation.
    Roestenberg M; McCall M; Hopman J; Wiersma J; Luty AJ; van Gemert GJ; van de Vegte-Bolmer M; van Schaijk B; Teelen K; Arens T; Spaarman L; de Mast Q; Roeffen W; Snounou G; Rénia L; van der Ven A; Hermsen CC; Sauerwein R
    N Engl J Med; 2009 Jul; 361(5):468-77. PubMed ID: 19641203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.